Akin Advises Pharmakon in $250 Million Senior Secured Term Loan to Zenas BioPharma

In relation to a $250 million senior secured term loan to Zenas BioPharma, Inc., a clinical-stage global biopharmaceutical company dedicated to becoming a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, Akin provided advice to the BioPharma Credit Investment funds and Pharmakon Advisors, LP, an investment management firm that specializes in offering strategic financing solutions to the life sciences industry.